Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Blood Advances|May 5, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE studyGiulia Gabrielli, Beatrice Casadei, Annalisa Chiappella, et al.
Critical Reviews in Oncology/Hematology|January 3, 2021
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paperAlessandro Busca, Chiara Cattaneo, Elena De Carolis, et al.
Blood Advances|May 12, 2023
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCLMaria Chiara Tisi, Riccardo Moia, Caterina Patti, et al.
Leukemia & Lymphoma|October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana LinfomiAnnalisa Arcari, Lucia Morello, Daniele Vallisa, et al.
Cancers|December 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo, et al.
Cancers|June 29, 2019
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12Francesco Autore, Paolo Strati, Idanna Innocenti, et al.
The Oncologist|December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Marco Frigeni, Laurent Alric, et al.
British Journal of Haematology|August 9, 2022
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative GroupSara Steffanoni, Teresa Calimeri, Alice Laurenge, et al.
Transplantation and Cellular Therapy|January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE StudyFederico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy|February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE StudyAngelica Barone, Federico Stella, Silva Ljevar, et al.
Pageof 6